Do RAAS Blockers Increase Susceptibility to COVID-19?
Hypertension, cardiovascular disease, and diabetes are common underlying conditions in individuals who contract COVID-19 and appear to increase the risk of death in these patients. That’s led to some speculation that drugs commonly used to treat those conditions, such as renin-angiotensin-aldosterone system (RAAS) blockers, could increase patients’ risk of getting COVID-19 or developing a more serious case of the disease. Here’s what you and your patients need to know. 

Need Another Reason to Urge Patients to Stop Smoking or
Vaping? COVID-19
With a pandemic racing around the globe that causes shortness of breath in mild cases and acute lung injury and death in severe cases, there’s never been a better time to stop smoking or vaping. Read on to learn how smoking and vaping increase risks associated with COVID-19. 

Talking With Patients About the Risks of COVID-19 “Miracle Drugs”
A small but encouraging study created excitement that old malaria drugs could provide a cheap and quick cure for COVID-19. The truth is more complicated, as the quinine derivatives and even the standby antibiotic azithromycin come with some significant caveats, particularly for individuals combatting a virus that affects as many systems in the body as COVID-19 does. Read more.